# Mark Haas

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-haas/

## Facts

| Field | Value |
| --- | --- |
| Citations | 38,104 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 93 |
| i10-index | 230 |
| Last Known Institution | Cedars-Sinai Medical Center |
| OpenAlex ID | https://openalex.org/A5062176433 |
| ORCID iD | https://orcid.org/0000-0002-7181-4664 |
| Works | 353 |

## Researcher papers

Showing 12 of 21.

- [Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions](https://scholariq.org/papers/banff-07-classification-of-renal-allograft-pathology-updates-and-future/)
- [Pathologic Classification of Diabetic Nephropathy](https://scholariq.org/papers/pathologic-classification-of-diabetic-nephropathy/)
- [VEGF Inhibition and Renal Thrombotic Microangiopathy](https://scholariq.org/papers/vegf-inhibition-and-renal-thrombotic-microangiopathy/)
- [Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions](https://scholariq.org/papers/banff-2013-meeting-report-inclusion-of-c4d-negative-antibody-mediated-rejection/)
- [The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-rationale-clinicopathological/)
- [Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group](https://scholariq.org/papers/oxford-classification-of-iga-nephropathy-2016-an-update-from-the-iga-nephropathy/)
- [The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-pathology-definitions-correlations/)
- [The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials](https://scholariq.org/papers/the-banff-2017-kidney-meeting-report-revised-diagnostic-criteria-for-chronic/)
- [Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices](https://scholariq.org/papers/revision-of-the-international-society-of-nephrology-renal-pathology-society/)
- [The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection](https://scholariq.org/papers/the-banff-2019-kidney-meeting-report-i-updates-on-and-clarification-of-criteria/)
- [C3 glomerulopathy: consensus report](https://scholariq.org/papers/c3-glomerulopathy-consensus-report/)
- [The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology](https://scholariq.org/papers/the-banff-2015-kidney-meeting-report-current-challenges-in-rejection/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)

## Researcher university

- [Cedars-Sinai Medical Center](https://scholariq.org/institutions/cedars-sinai-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.